Associate Professor, Radiology, Baylor College of Medicine
Radiation Oncology
Bin S. Teh, MB
|
|
Give Review
Bin S. Teh, MB works in the field of Radiation Oncology. He studied medicine at Baylor College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Bin S. Teh, MB is a published doctor. He has 100 papers published. The most current publication "Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions." He is registered with Medicare.
Publications
- Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma.
- Phase 2 multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.
- Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma.
- Comparison of supine and prone craniospinal irradiation in children with medulloblastoma.
- ACR Appropriateness Criteria(®) Non-Spine Bone Metastases.
- The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far?
- Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
- Emerging applications of stereotactic body radiotherapy.
- Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder Cancer models.
- A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
- Stereotactic body radiation therapy (SBRT) for an isolated bone metastasis in an adolescent male with nasopharyngeal carcinoma.
- Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part II: nonspinal tumors.
- Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part I: spinal tumors.
- Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
- Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: Clinical outcomes.
- Emerging role of stereotactic body radiotherapy in the treatment of pancreatic Cancer.
- Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
- Serious Complications Associated with Stereotactic Ablative Radiotherapy and Strategies to Mitigate the Risk.
- Rhabdomyosarcoma Arising in a Previously Irradiated Field: An Analysis of 43 Patients.
- Is There an Increase in Genitourinary Toxicity in Patients Treated With Transurethral Resection of the Prostate and Radiotherapy?: A Systematic Review.
- A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases.
- Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy.
- Hypofractionated radiotherapy for prostate Cancer.
- Treatment Trends and Outcomes of Small-Cell Carcinoma of the Bladder.
- Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate Cancer.
- Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma.
- The role of local therapy in the management of lung and liver oligometastases.
- A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: Epidemiology, Prognostic Variables, and Treatment Trends.
- MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway.
- The alkylphospholipid, perifosine, radiosensitizes prostate Cancer cells both in vitro and in vivo.
- Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia.
- Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
- Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary Glands.
- Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
- Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate Cancer.
- Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
- Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy.
- The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma.
- Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system.
- Helical tomotherapy significantly reduces dose to normal tissues when compared to 3D-CRT for locally advanced rectal Cancer.
- A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate.
- Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
- Radiosensitization by inhibiting STAT1 in renal cell carcinoma.
- Standardization of head and neck contouring using the acanthiomeatal line.
- Radiation-induced malignant gliomas: is there a role for reirradiation?
- Intensity-modulated radiation therapy in childhood ependymoma.
- Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist Hospital.
- Stereotactic body radiotherapy in the management of painful bone metastases.
- Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
- Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.
- Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical pros...
- Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
- 13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine.
- Computer visualization techniques (CVTs) foster evidence-based target delineation.
- Radiation proctopathy in the treatment of prostate Cancer.
- Radiation-induced moyamoya syndrome.
- Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.
- Long-term clinical response in leptomeningeal metastases from breast Cancer treated with capecitabine monotherapy: a case report.
- Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate Cancer patients.
- Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast Cancer.
- Radiation therapy in the management of brain metastases from renal cell carcinoma.
- Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate Cancer.
- Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate Cancer.
- Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate Cancer.
- Metastatic renal cell carcinoma to the nose and ethmoid sinus.
- Radiation-induced osteosarcomas in the pediatric population.
- Reirradiation in the era of IMRT: a dream or reality?
- Role of radiation therapy in a patient with primary pancreatic lymphoma.
- A molecular classification of papillary renal cell carcinoma.
- Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 1. Small-cell carcinoma of the urinary bladder.
- Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 2. Rhabdomyosarcoma of the urinary bladder in an adult.
- Treatment of brain tumors.
- Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate Cancer patients treated with Peacock/IMRT.
- Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate Cancer.
- Long-term treatment results of invasive cervical Cancer patients undergoing inadvertent hysterectomy followed by salvage radiotherapy.
- Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate Cancer patients.
- Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate Cancer-interim...
- Salvage radiotherapy for recurrent prostate Cancer after radical prostatectomy.
- Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
- Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
- Predictors of extracapsular extension and its radial distance in prostate Cancer: implications for prostate IMRT, brachytherapy, and surgery.
- Rare case of metastatic prostate adenocarcinoma to the Pituitary.
- Dosimetric predictors of xerostomia for head-and-neck Cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
- IMRT for prostate Cancer: defining target volume based on correlated pathologic volume of disease.
- The evolution of quality assurance for intensity- modulated radiation therapy (IMRT): sequential tomotherapy.
- HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus.
- Prostate adenocarcinoma presenting with inguinal lymphadenopathy.
- Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
- Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery.
- Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma.
- Using technology to decrease xerostomia for head and neck Cancer patients treated with radiation therapy.
- The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate Gland immobilization device?
- Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function.
- Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse Cancer model.
- Intensity-modulated radiation therapy (IMRT) for meningioma.
- Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
- Prostate immobilization using a rectal balloon.
- Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate Cancer with the use of rectal balloon for prostate immobilization.
- Stereotactic body radiotherapy for pancreatic Cancer: recent progress and future directions.
Schools
Baylor University
Baylor College Of Med
Conditions Treated
- Pituitary Gland Cancer
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Baylor College of Medicine -
The University of Queensland Medical School
Hospital
-
Michael E. DeBakey Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1164414439 | |
| NPPES Provider LastName | TEH | |
| NPPES Provider FirstName | BIN | |
| NPPES Provider ZIPCode | 770302703 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 171.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 10.53 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164414439 |
| Last Name Of The Provider | TEH |
| First Name Of The Provider | BIN |
| View All |
Similar Doctors
|
|
Dr. Tiffany L. Morgan, DO |
|
|
Dr. David C. Blackburn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adeel Kaiser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry Mok, MD |
|
|
Dr. Elizabeth S. Bloom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert C. Chen, MD |
|
|
Dr. Clifton D. Fuller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Edson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack Phan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chelsea C. Pinnix, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simona F. Shaitelman, MD
This Doctor is OpenDoctor Recommended.
|